Chronic Kidney Disease and Risk of Mortality and Major Adverse Limb Events After Femoral Artery Endovascular Revascularization for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study
The risk of mortality risk after SFA endovascular revascularization incrementally increases with decreasing renal function. However, impaired renal function is not related to the risk of adverse limb events and supports femoral revascularization in these patients.
Authors
- Piotr Sobieszczyk
- Scott Kinlay (ORCID: https://orcid.org/0000-0001-7687-9136)
- Thomas M. Todoran (ORCID: https://orcid.org/0000-0003-1815-5943)
- Peter Evans (ORCID: https://orcid.org/0000-0002-6226-7195)
- Andrew C. Eisenhauer
Institutions
- Boston University (US)
- Brigham and Women's Hospital (US)
- Boston Medical Center (US)
- Harvard University (US)
- Medical University of South Carolina (US)
- VA Boston Healthcare System (US)
- University Medical Center (US)
- Ralph H. Johnson VA Medical Center (US)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2025-02-10
- DOI
- https://doi.org/10.1002/ccd.31447
- Citations
- 2
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 4.01